152P Discovery of best-in-class dual-acting A2AR/A2BR antagonists that are functional in high adenosine environment

Autor: Katagihallimath, N., Nandishaiah, R., Sharma, S., Venkatesan, S., Rao, R., Bharatham, N., Gupta, M., Kundu, D., Kotakonda, H. Kaushik, Kalainesan, R. Ramalingam, Reddy, S., Tewary, B., Muley, S., Gangoli, A., Uthappa, P. Chirapanda, Maitreyi, L., Venkatraman, B., Datta, S., Sody, S. V Rekha, Majumder, B., Hameed, S.

Publikováno v: In Immuno-Oncology and Technology December 2023 20 Supplement

Bureaucracy or streamlining the rules in 'Good Clinical Practice (GCP)'-has equipoise occurred?

Autor: Kotakonda HK; Bugworks Research India Private Ltd., Centre for Cellular & Molecular Platforms (C-CAMP), National Centre for Biological Sciences, TIFR, GKVK Campus, Bangalore 560065, India. Electronic address: harish@bugworksresearch.com., Jonnalagadda VG; Bugworks Research India Private Ltd., Centre for Cellular & Molecular Platforms (C-CAMP), National Centre for Biological Sciences, TIFR, GKVK Campus, Bangalore 560065, India., Venna SR; Bugworks Research India Private Ltd., Centre for Cellular & Molecular Platforms (C-CAMP), National Centre for Biological Sciences, TIFR, GKVK Campus, Bangalore 560065, India.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 May; Vol. 34 (5), pp. 497-498. Date of Electronic Publication: 2023 Feb 16.